Global Antimicrobial Nanocoatings Market
As the global economy mends, the 2021 growth of Antimicrobial Nanocoatings will have significant ... Read More
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Anti-Infective Vaccines Annual Sales 2017-2028 2.1.2 World Current & Future Analysis for Anti-Infective Vaccines by Geographic Region, 2017, 2022 & 2028 2.1.3 World Current & Future Analysis for Anti-Infective Vaccines by Country/Region, 2017, 2022 & 2028 2.2 Anti-Infective Vaccines Segment by Type 2.2.1 Inactivated Vaccines 2.2.2 Conjugate Vaccines 2.2.3 Live/attenuated Vaccines 2.3 Anti-Infective Vaccines Sales by Type 2.3.1 Global Anti-Infective Vaccines Sales Market Share by Type (2017-2022) 2.3.2 Global Anti-Infective Vaccines Revenue and Market Share by Type (2017-2022) 2.3.3 Global Anti-Infective Vaccines Sale Price by Type (2017-2022) 2.4 Anti-Infective Vaccines Segment by Application 2.4.1 Bacterial Diseases 2.4.2 Viral Diseases 2.5 Anti-Infective Vaccines Sales by Application 2.5.1 Global Anti-Infective Vaccines Sale Market Share by Application (2017-2022) 2.5.2 Global Anti-Infective Vaccines Revenue and Market Share by Application (2017-2022) 2.5.3 Global Anti-Infective Vaccines Sale Price by Application (2017-2022) 3 Global Anti-Infective Vaccines by Company 3.1 Global Anti-Infective Vaccines Breakdown Data by Company 3.1.1 Global Anti-Infective Vaccines Annual Sales by Company (2020-2022) 3.1.2 Global Anti-Infective Vaccines Sales Market Share by Company (2020-2022) 3.2 Global Anti-Infective Vaccines Annual Revenue by Company (2020-2022) 3.2.1 Global Anti-Infective Vaccines Revenue by Company (2020-2022) 3.2.2 Global Anti-Infective Vaccines Revenue Market Share by Company (2020-2022) 3.3 Global Anti-Infective Vaccines Sale Price by Company 3.4 Key Manufacturers Anti-Infective Vaccines Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Anti-Infective Vaccines Product Location Distribution 3.4.2 Players Anti-Infective Vaccines Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Anti-Infective Vaccines by Geographic Region 4.1 World Historic Anti-Infective Vaccines Market Size by Geographic Region (2017-2022) 4.1.1 Global Anti-Infective Vaccines Annual Sales by Geographic Region (2017-2022) 4.1.2 Global Anti-Infective Vaccines Annual Revenue by Geographic Region 4.2 World Historic Anti-Infective Vaccines Market Size by Country/Region (2017-2022) 4.2.1 Global Anti-Infective Vaccines Annual Sales by Country/Region (2017-2022) 4.2.2 Global Anti-Infective Vaccines Annual Revenue by Country/Region 4.3 Americas Anti-Infective Vaccines Sales Growth 4.4 APAC Anti-Infective Vaccines Sales Growth 4.5 Europe Anti-Infective Vaccines Sales Growth 4.6 Middle East & Africa Anti-Infective Vaccines Sales Growth 5 Americas 5.1 Americas Anti-Infective Vaccines Sales by Country 5.1.1 Americas Anti-Infective Vaccines Sales by Country (2017-2022) 5.1.2 Americas Anti-Infective Vaccines Revenue by Country (2017-2022) 5.2 Americas Anti-Infective Vaccines Sales by Type 5.3 Americas Anti-Infective Vaccines Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Anti-Infective Vaccines Sales by Region 6.1.1 APAC Anti-Infective Vaccines Sales by Region (2017-2022) 6.1.2 APAC Anti-Infective Vaccines Revenue by Region (2017-2022) 6.2 APAC Anti-Infective Vaccines Sales by Type 6.3 APAC Anti-Infective Vaccines Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Anti-Infective Vaccines by Country 7.1.1 Europe Anti-Infective Vaccines Sales by Country (2017-2022) 7.1.2 Europe Anti-Infective Vaccines Revenue by Country (2017-2022) 7.2 Europe Anti-Infective Vaccines Sales by Type 7.3 Europe Anti-Infective Vaccines Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Anti-Infective Vaccines by Country 8.1.1 Middle East & Africa Anti-Infective Vaccines Sales by Country (2017-2022) 8.1.2 Middle East & Africa Anti-Infective Vaccines Revenue by Country (2017-2022) 8.2 Middle East & Africa Anti-Infective Vaccines Sales by Type 8.3 Middle East & Africa Anti-Infective Vaccines Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Anti-Infective Vaccines 10.3 Manufacturing Process Analysis of Anti-Infective Vaccines 10.4 Industry Chain Structure of Anti-Infective Vaccines 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Anti-Infective Vaccines Distributors 11.3 Anti-Infective Vaccines Customer 12 World Forecast Review for Anti-Infective Vaccines by Geographic Region 12.1 Global Anti-Infective Vaccines Market Size Forecast by Region 12.1.1 Global Anti-Infective Vaccines Forecast by Region (2023-2028) 12.1.2 Global Anti-Infective Vaccines Annual Revenue Forecast by Region (2023-2028) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Anti-Infective Vaccines Forecast by Type 12.7 Global Anti-Infective Vaccines Forecast by Application 13 Key Players Analysis 13.1 Emergent BioDefense Operations Lansing Inc. 13.1.1 Emergent BioDefense Operations Lansing Inc. Company Information 13.1.2 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Offered 13.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022) 13.1.4 Emergent BioDefense Operations Lansing Inc. Main Business Overview 13.1.5 Emergent BioDefense Operations Lansing Inc. Latest Developments 13.2 Sanofi Pasteur 13.2.1 Sanofi Pasteur Company Information 13.2.2 Sanofi Pasteur Anti-Infective Vaccines Product Offered 13.2.3 Sanofi Pasteur Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022) 13.2.4 Sanofi Pasteur Main Business Overview 13.2.5 Sanofi Pasteur Latest Developments 13.3 Merck & Co. 13.3.1 Merck & Co. Company Information 13.3.2 Merck & Co. Anti-Infective Vaccines Product Offered 13.3.3 Merck & Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022) 13.3.4 Merck & Co. Main Business Overview 13.3.5 Merck & Co. Latest Developments 13.4 MedImmune LLC 13.4.1 MedImmune LLC Company Information 13.4.2 MedImmune LLC Anti-Infective Vaccines Product Offered 13.4.3 MedImmune LLC Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022) 13.4.4 MedImmune LLC Main Business Overview 13.4.5 MedImmune LLC Latest Developments 13.5 Novartis Vaccines 13.5.1 Novartis Vaccines Company Information 13.5.2 Novartis Vaccines Anti-Infective Vaccines Product Offered 13.5.3 Novartis Vaccines Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022) 13.5.4 Novartis Vaccines Main Business Overview 13.5.5 Novartis Vaccines Latest Developments 13.6 Diagnostics Ltd. 13.6.1 Diagnostics Ltd. Company Information 13.6.2 Diagnostics Ltd. Anti-Infective Vaccines Product Offered 13.6.3 Diagnostics Ltd. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022) 13.6.4 Diagnostics Ltd. Main Business Overview 13.6.5 Diagnostics Ltd. Latest Developments 13.7 Intercell Biomedical 13.7.1 Intercell Biomedical Company Information 13.7.2 Intercell Biomedical Anti-Infective Vaccines Product Offered 13.7.3 Intercell Biomedical Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022) 13.7.4 Intercell Biomedical Main Business Overview 13.7.5 Intercell Biomedical Latest Developments 13.8 MassBiologics 13.8.1 MassBiologics Company Information 13.8.2 MassBiologics Anti-Infective Vaccines Product Offered 13.8.3 MassBiologics Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022) 13.8.4 MassBiologics Main Business Overview 13.8.5 MassBiologics Latest Developments 13.9 Barr Labs, Inc. 13.9.1 Barr Labs, Inc. Company Information 13.9.2 Barr Labs, Inc. Anti-Infective Vaccines Product Offered 13.9.3 Barr Labs, Inc. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022) 13.9.4 Barr Labs, Inc. Main Business Overview 13.9.5 Barr Labs, Inc. Latest Developments 13.10 Organon Teknika Co. 13.10.1 Organon Teknika Co. Company Information 13.10.2 Organon Teknika Co. Anti-Infective Vaccines Product Offered 13.10.3 Organon Teknika Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022) 13.10.4 Organon Teknika Co. Main Business Overview 13.10.5 Organon Teknika Co. Latest Developments 13.11 GlaxoSmithKline Biologicals 13.11.1 GlaxoSmithKline Biologicals Company Information 13.11.2 GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Offered 13.11.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022) 13.11.4 GlaxoSmithKline Biologicals Main Business Overview 13.11.5 GlaxoSmithKline Biologicals Latest Developments 13.12 CSL Ltd. 13.12.1 CSL Ltd. Company Information 13.12.2 CSL Ltd. Anti-Infective Vaccines Product Offered 13.12.3 CSL Ltd. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022) 13.12.4 CSL Ltd. Main Business Overview 13.12.5 CSL Ltd. Latest Developments 13.13 ID Biomedical Co. 13.13.1 ID Biomedical Co. Company Information 13.13.2 ID Biomedical Co. Anti-Infective Vaccines Product Offered 13.13.3 ID Biomedical Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022) 13.13.4 ID Biomedical Co. Main Business Overview 13.13.5 ID Biomedical Co. Latest Developments 13.14 Protein Sciences Co. 13.14.1 Protein Sciences Co. Company Information 13.14.2 Protein Sciences Co. Anti-Infective Vaccines Product Offered 13.14.3 Protein Sciences Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022) 13.14.4 Protein Sciences Co. Main Business Overview 13.14.5 Protein Sciences Co. Latest Developments 13.15 Wyeth Pharmaceuticals, Inc. 13.15.1 Wyeth Pharmaceuticals, Inc. Company Information 13.15.2 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Offered 13.15.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022) 13.15.4 Wyeth Pharmaceuticals, Inc. Main Business Overview 13.15.5 Wyeth Pharmaceuticals, Inc. Latest Developments 13.16 Berna Biotech 13.16.1 Berna Biotech Company Information 13.16.2 Berna Biotech Anti-Infective Vaccines Product Offered 13.16.3 Berna Biotech Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022) 13.16.4 Berna Biotech Main Business Overview 13.16.5 Berna Biotech Latest Developments 14 Research Findings and Conclusion
List of Tables Table 1. Anti-Infective Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions) Table 2. Anti-Infective Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions) Table 3. Major Players of Inactivated Vaccines Table 4. Major Players of Conjugate Vaccines Table 5. Major Players of Live/attenuated Vaccines Table 6. Global Anti-Infective Vaccines Sales by Type (2017-2022) & (Units) Table 7. Global Anti-Infective Vaccines Sales Market Share by Type (2017-2022) Table 8. Global Anti-Infective Vaccines Revenue by Type (2017-2022) & ($ million) Table 9. Global Anti-Infective Vaccines Revenue Market Share by Type (2017-2022) Table 10. Global Anti-Infective Vaccines Sale Price by Type (2017-2022) & (US$/Unit) Table 11. Global Anti-Infective Vaccines Sales by Application (2017-2022) & (Units) Table 12. Global Anti-Infective Vaccines Sales Market Share by Application (2017-2022) Table 13. Global Anti-Infective Vaccines Revenue by Application (2017-2022) Table 14. Global Anti-Infective Vaccines Revenue Market Share by Application (2017-2022) Table 15. Global Anti-Infective Vaccines Sale Price by Application (2017-2022) & (US$/Unit) Table 16. Global Anti-Infective Vaccines Sales by Company (2020-2022) & (Units) Table 17. Global Anti-Infective Vaccines Sales Market Share by Company (2020-2022) Table 18. Global Anti-Infective Vaccines Revenue by Company (2020-2022) ($ Millions) Table 19. Global Anti-Infective Vaccines Revenue Market Share by Company (2020-2022) Table 20. Global Anti-Infective Vaccines Sale Price by Company (2020-2022) & (US$/Unit) Table 21. Key Manufacturers Anti-Infective Vaccines Producing Area Distribution and Sales Area Table 22. Players Anti-Infective Vaccines Products Offered Table 23. Anti-Infective Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 24. New Products and Potential Entrants Table 25. Mergers & Acquisitions, Expansion Table 26. Global Anti-Infective Vaccines Sales by Geographic Region (2017-2022) & (Units) Table 27. Global Anti-Infective Vaccines Sales Market Share Geographic Region (2017-2022) Table 28. Global Anti-Infective Vaccines Revenue by Geographic Region (2017-2022) & ($ millions) Table 29. Global Anti-Infective Vaccines Revenue Market Share by Geographic Region (2017-2022) Table 30. Global Anti-Infective Vaccines Sales by Country/Region (2017-2022) & (Units) Table 31. Global Anti-Infective Vaccines Sales Market Share by Country/Region (2017-2022) Table 32. Global Anti-Infective Vaccines Revenue by Country/Region (2017-2022) & ($ millions) Table 33. Global Anti-Infective Vaccines Revenue Market Share by Country/Region (2017-2022) Table 34. Americas Anti-Infective Vaccines Sales by Country (2017-2022) & (Units) Table 35. Americas Anti-Infective Vaccines Sales Market Share by Country (2017-2022) Table 36. Americas Anti-Infective Vaccines Revenue by Country (2017-2022) & ($ Millions) Table 37. Americas Anti-Infective Vaccines Revenue Market Share by Country (2017-2022) Table 38. Americas Anti-Infective Vaccines Sales by Type (2017-2022) & (Units) Table 39. Americas Anti-Infective Vaccines Sales Market Share by Type (2017-2022) Table 40. Americas Anti-Infective Vaccines Sales by Application (2017-2022) & (Units) Table 41. Americas Anti-Infective Vaccines Sales Market Share by Application (2017-2022) Table 42. APAC Anti-Infective Vaccines Sales by Region (2017-2022) & (Units) Table 43. APAC Anti-Infective Vaccines Sales Market Share by Region (2017-2022) Table 44. APAC Anti-Infective Vaccines Revenue by Region (2017-2022) & ($ Millions) Table 45. APAC Anti-Infective Vaccines Revenue Market Share by Region (2017-2022) Table 46. APAC Anti-Infective Vaccines Sales by Type (2017-2022) & (Units) Table 47. APAC Anti-Infective Vaccines Sales Market Share by Type (2017-2022) Table 48. APAC Anti-Infective Vaccines Sales by Application (2017-2022) & (Units) Table 49. APAC Anti-Infective Vaccines Sales Market Share by Application (2017-2022) Table 50. Europe Anti-Infective Vaccines Sales by Country (2017-2022) & (Units) Table 51. Europe Anti-Infective Vaccines Sales Market Share by Country (2017-2022) Table 52. Europe Anti-Infective Vaccines Revenue by Country (2017-2022) & ($ Millions) Table 53. Europe Anti-Infective Vaccines Revenue Market Share by Country (2017-2022) Table 54. Europe Anti-Infective Vaccines Sales by Type (2017-2022) & (Units) Table 55. Europe Anti-Infective Vaccines Sales Market Share by Type (2017-2022) Table 56. Europe Anti-Infective Vaccines Sales by Application (2017-2022) & (Units) Table 57. Europe Anti-Infective Vaccines Sales Market Share by Application (2017-2022) Table 58. Middle East & Africa Anti-Infective Vaccines Sales by Country (2017-2022) & (Units) Table 59. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Country (2017-2022) Table 60. Middle East & Africa Anti-Infective Vaccines Revenue by Country (2017-2022) & ($ Millions) Table 61. Middle East & Africa Anti-Infective Vaccines Revenue Market Share by Country (2017-2022) Table 62. Middle East & Africa Anti-Infective Vaccines Sales by Type (2017-2022) & (Units) Table 63. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Type (2017-2022) Table 64. Middle East & Africa Anti-Infective Vaccines Sales by Application (2017-2022) & (Units) Table 65. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Application (2017-2022) Table 66. Key Market Drivers & Growth Opportunities of Anti-Infective Vaccines Table 67. Key Market Challenges & Risks of Anti-Infective Vaccines Table 68. Key Industry Trends of Anti-Infective Vaccines Table 69. Anti-Infective Vaccines Raw Material Table 70. Key Suppliers of Raw Materials Table 71. Anti-Infective Vaccines Distributors List Table 72. Anti-Infective Vaccines Customer List Table 73. Global Anti-Infective Vaccines Sales Forecast by Region (2023-2028) & (Units) Table 74. Global Anti-Infective Vaccines Sales Market Forecast by Region Table 75. Global Anti-Infective Vaccines Revenue Forecast by Region (2023-2028) & ($ millions) Table 76. Global Anti-Infective Vaccines Revenue Market Share Forecast by Region (2023-2028) Table 77. Americas Anti-Infective Vaccines Sales Forecast by Country (2023-2028) & (Units) Table 78. Americas Anti-Infective Vaccines Revenue Forecast by Country (2023-2028) & ($ millions) Table 79. APAC Anti-Infective Vaccines Sales Forecast by Region (2023-2028) & (Units) Table 80. APAC Anti-Infective Vaccines Revenue Forecast by Region (2023-2028) & ($ millions) Table 81. Europe Anti-Infective Vaccines Sales Forecast by Country (2023-2028) & (Units) Table 82. Europe Anti-Infective Vaccines Revenue Forecast by Country (2023-2028) & ($ millions) Table 83. Middle East & Africa Anti-Infective Vaccines Sales Forecast by Country (2023-2028) & (Units) Table 84. Middle East & Africa Anti-Infective Vaccines Revenue Forecast by Country (2023-2028) & ($ millions) Table 85. Global Anti-Infective Vaccines Sales Forecast by Type (2023-2028) & (Units) Table 86. Global Anti-Infective Vaccines Sales Market Share Forecast by Type (2023-2028) Table 87. Global Anti-Infective Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions) Table 88. Global Anti-Infective Vaccines Revenue Market Share Forecast by Type (2023-2028) Table 89. Global Anti-Infective Vaccines Sales Forecast by Application (2023-2028) & (Units) Table 90. Global Anti-Infective Vaccines Sales Market Share Forecast by Application (2023-2028) Table 91. Global Anti-Infective Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions) Table 92. Global Anti-Infective Vaccines Revenue Market Share Forecast by Application (2023-2028) Table 93. Emergent BioDefense Operations Lansing Inc. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors Table 94. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Offered Table 95. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 96. Emergent BioDefense Operations Lansing Inc. Main Business Table 97. Emergent BioDefense Operations Lansing Inc. Latest Developments Table 98. Sanofi Pasteur Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors Table 99. Sanofi Pasteur Anti-Infective Vaccines Product Offered Table 100. Sanofi Pasteur Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 101. Sanofi Pasteur Main Business Table 102. Sanofi Pasteur Latest Developments Table 103. Merck & Co. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors Table 104. Merck & Co. Anti-Infective Vaccines Product Offered Table 105. Merck & Co. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 106. Merck & Co. Main Business Table 107. Merck & Co. Latest Developments Table 108. MedImmune LLC Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors Table 109. MedImmune LLC Anti-Infective Vaccines Product Offered Table 110. MedImmune LLC Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 111. MedImmune LLC Main Business Table 112. MedImmune LLC Latest Developments Table 113. Novartis Vaccines Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors Table 114. Novartis Vaccines Anti-Infective Vaccines Product Offered Table 115. Novartis Vaccines Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 116. Novartis Vaccines Main Business Table 117. Novartis Vaccines Latest Developments Table 118. Diagnostics Ltd. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors Table 119. Diagnostics Ltd. Anti-Infective Vaccines Product Offered Table 120. Diagnostics Ltd. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 121. Diagnostics Ltd. Main Business Table 122. Diagnostics Ltd. Latest Developments Table 123. Intercell Biomedical Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors Table 124. Intercell Biomedical Anti-Infective Vaccines Product Offered Table 125. Intercell Biomedical Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 126. Intercell Biomedical Main Business Table 127. Intercell Biomedical Latest Developments Table 128. MassBiologics Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors Table 129. MassBiologics Anti-Infective Vaccines Product Offered Table 130. MassBiologics Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 131. MassBiologics Main Business Table 132. MassBiologics Latest Developments Table 133. Barr Labs, Inc. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors Table 134. Barr Labs, Inc. Anti-Infective Vaccines Product Offered Table 135. Barr Labs, Inc. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 136. Barr Labs, Inc. Main Business Table 137. Barr Labs, Inc. Latest Developments Table 138. Organon Teknika Co. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors Table 139. Organon Teknika Co. Anti-Infective Vaccines Product Offered Table 140. Organon Teknika Co. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 141. Organon Teknika Co. Main Business Table 142. Organon Teknika Co. Latest Developments Table 143. GlaxoSmithKline Biologicals Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors Table 144. GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Offered Table 145. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 146. GlaxoSmithKline Biologicals Main Business Table 147. GlaxoSmithKline Biologicals Latest Developments Table 148. CSL Ltd. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors Table 149. CSL Ltd. Anti-Infective Vaccines Product Offered Table 150. CSL Ltd. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 151. CSL Ltd. Main Business Table 152. CSL Ltd. Latest Developments Table 153. ID Biomedical Co. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors Table 154. ID Biomedical Co. Anti-Infective Vaccines Product Offered Table 155. ID Biomedical Co. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 156. ID Biomedical Co. Main Business Table 157. ID Biomedical Co. Latest Developments Table 158. Protein Sciences Co. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors Table 159. Protein Sciences Co. Anti-Infective Vaccines Product Offered Table 160. Protein Sciences Co. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 161. Protein Sciences Co. Main Business Table 162. Protein Sciences Co. Latest Developments Table 163. Wyeth Pharmaceuticals, Inc. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors Table 164. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Offered Table 165. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 166. Wyeth Pharmaceuticals, Inc. Main Business Table 167. Wyeth Pharmaceuticals, Inc. Latest Developments Table 168. Berna Biotech Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors Table 169. Berna Biotech Anti-Infective Vaccines Product Offered Table 170. Berna Biotech Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 171. Berna Biotech Main Business Table 172. Berna Biotech Latest Developments List of Figures Figure 1. Picture of Anti-Infective Vaccines Figure 2. Anti-Infective Vaccines Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Anti-Infective Vaccines Sales Growth Rate 2017-2028 (Units) Figure 7. Global Anti-Infective Vaccines Revenue Growth Rate 2017-2028 ($ Millions) Figure 8. Anti-Infective Vaccines Sales by Region (2021 & 2028) & ($ millions) Figure 9. Product Picture of Inactivated Vaccines Figure 10. Product Picture of Conjugate Vaccines Figure 11. Product Picture of Live/attenuated Vaccines Figure 12. Global Anti-Infective Vaccines Sales Market Share by Type in 2021 Figure 13. Global Anti-Infective Vaccines Revenue Market Share by Type (2017-2022) Figure 14. Anti-Infective Vaccines Consumed in Bacterial Diseases Figure 15. Global Anti-Infective Vaccines Market: Bacterial Diseases (2017-2022) & (Units) Figure 16. Anti-Infective Vaccines Consumed in Viral Diseases Figure 17. Global Anti-Infective Vaccines Market: Viral Diseases (2017-2022) & (Units) Figure 18. Global Anti-Infective Vaccines Sales Market Share by Application (2017-2022) Figure 19. Global Anti-Infective Vaccines Revenue Market Share by Application in 2021 Figure 20. Anti-Infective Vaccines Revenue Market by Company in 2021 ($ Million) Figure 21. Global Anti-Infective Vaccines Revenue Market Share by Company in 2021 Figure 22. Global Anti-Infective Vaccines Sales Market Share by Geographic Region (2017-2022) Figure 23. Global Anti-Infective Vaccines Revenue Market Share by Geographic Region in 2021 Figure 24. Global Anti-Infective Vaccines Sales Market Share by Region (2017-2022) Figure 25. Global Anti-Infective Vaccines Revenue Market Share by Country/Region in 2021 Figure 26. Americas Anti-Infective Vaccines Sales 2017-2022 (Units) Figure 27. Americas Anti-Infective Vaccines Revenue 2017-2022 ($ Millions) Figure 28. APAC Anti-Infective Vaccines Sales 2017-2022 (Units) Figure 29. APAC Anti-Infective Vaccines Revenue 2017-2022 ($ Millions) Figure 30. Europe Anti-Infective Vaccines Sales 2017-2022 (Units) Figure 31. Europe Anti-Infective Vaccines Revenue 2017-2022 ($ Millions) Figure 32. Middle East & Africa Anti-Infective Vaccines Sales 2017-2022 (Units) Figure 33. Middle East & Africa Anti-Infective Vaccines Revenue 2017-2022 ($ Millions) Figure 34. Americas Anti-Infective Vaccines Sales Market Share by Country in 2021 Figure 35. Americas Anti-Infective Vaccines Revenue Market Share by Country in 2021 Figure 36. United States Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions) Figure 37. Canada Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions) Figure 38. Mexico Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions) Figure 39. Brazil Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions) Figure 40. APAC Anti-Infective Vaccines Sales Market Share by Region in 2021 Figure 41. APAC Anti-Infective Vaccines Revenue Market Share by Regions in 2021 Figure 42. China Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions) Figure 43. Japan Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions) Figure 44. South Korea Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions) Figure 45. Southeast Asia Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions) Figure 46. India Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions) Figure 47. Australia Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions) Figure 48. Europe Anti-Infective Vaccines Sales Market Share by Country in 2021 Figure 49. Europe Anti-Infective Vaccines Revenue Market Share by Country in 2021 Figure 50. Germany Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions) Figure 51. France Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions) Figure 52. UK Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions) Figure 53. Italy Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions) Figure 54. Russia Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions) Figure 55. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Country in 2021 Figure 56. Middle East & Africa Anti-Infective Vaccines Revenue Market Share by Country in 2021 Figure 57. Egypt Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions) Figure 58. South Africa Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions) Figure 59. Israel Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions) Figure 60. Turkey Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions) Figure 61. GCC Country Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions) Figure 62. Manufacturing Cost Structure Analysis of Anti-Infective Vaccines in 2021 Figure 63. Manufacturing Process Analysis of Anti-Infective Vaccines Figure 64. Industry Chain Structure of Anti-Infective Vaccines Figure 65. Channels of Distribution Figure 66. Distributors Profiles
As the global economy mends, the 2021 growth of Antimicrobial Nanocoatings will have significant ... Read More
As the global economy mends, the 2021 growth of Antioxidant BHT will have significant change from ... Read More
As the global economy mends, the 2021 growth of Anti-Reflective Glass Coatings will have signific ... Read More
As the global economy mends, the 2021 growth of Antisense and RNAi Therapeutics will have signifi ... Read More